Table 2.

The relationship between patient related factors, overall survival and disease-free survival in patients undergoing potentially curative resection for esophageal cancer

		Disease-free survival		Overall survival
Clinico-pathological variables	Frequency n (%)	5-Year survival rate (%)	p-value	5-year survival rate (%)	p-value
Age (years)					0.991
< 65	100 (34.0)	47.2	0.581	44.4
65–75	141 (48.0)	43.1		43.1
> 75 years	53 (18.0)	54.1		43.2
Sex					0.714
Female	44 (15.0)	52.6	0.617	47.4
Male	250 (85.0)	46.4		42.9
White Cell count					0.876
Low	20 (6.8)	50.0	0.878	50.0
Normal	269 (91.5)	47.5		43.3
High	5 (1.7)	33.3		33.3
Neutrophil count					0.743
Low	280 (95.2)	47.2	0.893	43.2
High	14 (4.8)	50.0		50.0
Lymphocyte count					0.501
Low	44 (15.0)	47.1	0.623	41.2
Normal	242 (82.3)	46.3		42.6
High	8 (2.7)	66.7		66.7
Platelet count					0.042
Low	286 (97.3)	46.1	0.065	42.2
High	8 (2.7)	100.0		100.0
C-Reactive Protein					0.585
Normal	247 (84.0)	49.1	0.355	44.5
High	47 (16.0)	38.1		38.1
Albumin					0.984
Normal	245 (83.3)	47.8	0.760	43.5
Low	49 (16.7)	43.8		43.8
Derivative markers
Neutrophil–Lymphocyte Ratio					0.137
Low	263 (89.5)	45.3	0.233	49.6
High	31 (10.5)	28.6		28.6
Neutrophil–Platelet Score					0.147
Low	273 (92.9)	45.9	0.229	41.8
Intermediate	20 (6.8)	66.7		66.7
High	1 (0.3)	N/A		N/A
Platelet–Lymphocyte Ratio					0.765
Low	137 (46.6)	48.4	0.804	42.2
High	157 (53.4)	46.3		44.8
Modified Glasgow prognostic Score					0.593
Low	247 (84.0)	49.1	0.452	44.5
Intermediate	28 (9.5)	30.8		30.8
High	19 (6.5)	50.0		50.0